Clinical Trial: The Purpose of the Study is to Evaluate the Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain

U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795554) titled 'The Purpose of the Study is to Evaluate the Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain' on Aug. 26.

Brief Summary: Antipsychotic-induced metabolic disturbances, especially weight gain, are common in patients with schizophrenia. There are no hitherto effective treatments for reducing antipsychotic-induced weight gain. Recently, research suggest that Accelerated dTMS (a-dTMS) which deliver more than one daily TMS session indicates greater efficacy than other TMS treatment. Symptom provocation is believed to improve the clinical responses to TMS. In this study, we, firstly, evaluate the safety and e...